On Tuesday shares of Karyopharm Therapeutics, Inc. (NASDAQ:KPTI) closed at $31.22. Company’s EPS growth for next 5 years is recorded as -13.60%. On 1 April 2015, Karyopharm Therapeutics (NASDAQ: KPTI) announced the appointment of Mikael Dolsten, MD, PhD, President of Pfizer Worldwide Research and Development of Pfizer Inc., to the company’s board of directors.
CorMedix, Inc. (NYSEMKT:CRMD) in last trading activity increased 5.24% to close at $9.24. Company weekly performance is 6.21% while its quarterly performance stands at 399.46%. CorMedix, Inc. (NYSEMKT:CRMD) is -11.15% away from its 52 week high. CorMedix Inc. (NYSE MKT: CRMD), announced that the extension to April 30, 2015 of the expiration date applies to all publicly traded warrants.
On last trading day CACI International Inc. (NYSE:CACI) moved down -0.47% to close at $87.67. Its volatility for the week is 1.35% while volatility for the month is 1.70%. CACI’s sales growth for past 5 years was 5.50% and its EPS growth for past 5 years was 12.80%. CACI International Inc. (NYSE:CACI) monthly performance is 1.00%. On 1 April 2015, CACI International (NYSE: CACI) has acquired LTC Engineering Associates, Inc., a highly specialized provider of technical engineering solutions and services to the Intelligence and Department of Defense communities in the areas of software engineering, cybersecurity, signals intelligence (SIGINT) and communications intelligence (COMINT), and digital signals processing.
Microsoft Corporation (NASDAQ:MSFT) has 3.00% insider ownership while its institutional ownership stands at 73.00%. In last trading activity company’s stock closed at $41.53. HP announced it is partnering with Microsoft Corp. (NASDAQ:MSFT) to deliver solutions for the automotive, public sector and financial services industries to help organizations quickly deliver differentiated products and create new revenue through mobile, web and social channels.
On last trading day General Electric Company (NYSE:GE) fell -0.64% to close at $25.02. Its volatility for the week is 1.48% while volatility for the month is 1.41%. GE’s sales growth for past 5 years was -0.80% and its EPS growth for past 5 years was 8.80%. General Electric Company (NYSE:GE) monthly performance is -1.57%.Vetr lowered shares of General Electric Company (NYSE:GE) from a strong-buy rating to a buy rating in a research report released.